Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2004-05-25 · Nuclear Regulatory Commission · Notices

Notices. Notice of Availability of Environmental Assessment and Finding of No Significant Impact

551 words·~3 min read·/register/2004/05/25/04-11758

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 7590-01-P NUCLEAR REGULATORY COMMISSION [Docket No. 030-34781] Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment for Message Pharmaceuticals, Inc.'s Facility in Malvern, PA AGENCY: Nuclear Regulatory Commission. ACTION: Notice of Availability of Environmental Assessment and Finding of No Significant Impact. FOR FURTHER INFORMATION CONTACT: Sattar Lodhi, Nuclear Materials Safety Branch 2, Division of Nuclear Materials Safety, Region I, 475 Allendale Road, King of Prussia, Pennsylvania, 19406, telephone
(610)337-5364 fax
(610)337-5269; or by e-mail: *asl@nrc.gov.* SUPPLEMENTARY INFORMATION: I. Introduction The Nuclear Regulatory Commission
(NRC)is considering the issuance of a license amendment to Message Pharmaceuticals, Inc.'s Materials License No. 37-30462-01, to authorize release of its facility in Malvern, Pennsylvania for unrestricted use. NRC has prepared an Environmental Assessment
(EA)in support of this action in accordance with the requirements of 10 CFR part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. The amendment will be issued following the publication of this Notice. II. EA Summary The purpose of the proposed action is to authorize the release of the licensee's Malvern, Pennsylvania facility for unrestricted use. Message Pharmaceuticals, Inc., was authorized by NRC from July 29, 1998, to use radioactive materials for research and development purposes at the site. On January 5, 2004, Message Pharmaceuticals, Inc., requested that NRC release the facility for unrestricted use. Message Pharmaceuticals, Inc., has conducted surveys of the facility and determined that the facility meets the license termination criteria in Subpart E of 10 CFR part 20. The NRC staff has prepared an EA in support of the proposed license amendment. III. Finding of No Significant Impact The staff has prepared the EA (summarized above) in support of the proposed license amendment to terminate the license and release the facility for unrestricted use. The NRC staff has evaluated Message Pharmaceuticals, Inc.'s request and the results of the surveys and has concluded that the completed action complies with the criteria in Subpart E of 10 CFR part 20. The staff has found that the environmental impacts from the proposed action are bounded by the impacts evaluated by the “Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Facilities” (NUREG-1496). On the basis of the EA, the NRC has concluded that the environmental impacts from the proposed action are expected to be insignificant and has determined not to prepare an environmental impact statement for the proposed action. IV. Further Information The EA and the documents related to this proposed action, including the application for the license amendment and supporting documentation, are available for inspection at NRC's Public Electronic Reading Room at *http://www.nrc.gov/reading-rm/adams.html* (ADAMS Accession Nos. ML040250011 and ML041040862). These documents are also available for inspection and copying for a fee at the Region I Office, 475 Allendale Road, King of Prussia, Pennsylvania, 19406. Persons who do not have access to ADAMS, should contact the NRC PDR Reference staff by telephone at 1-800-397-4209 or
(301)415-4737, of by e-mail to *pdr@nrc.gov.* For the Nuclear Regulatory Commission. Dated at King of Prussia, Pennsylvania this 18th day of May, 2004. John D. Kinneman, Chief, Nuclear Materials Safety Branch 2, Division of Nuclear Materials Safety Region I . [FR Doc. 04-11758 Filed 5-24-04; 8:45 am]
Connections2 off-index
2 references not yet in our index
  • 10 CFR 51
  • 10 CFR 20
Citation graph
cites case law
Notices
Notice of Availability of Environmental Assessment and Finding of No Significant Impact
Cite10 CFR 51
Cite10 CFR 20
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.